PUBLISHER: iData Research Inc. | PRODUCT CODE: 1676628
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1676628
The global orthopedic cartilage repair market was valued at $405 million in 2024 and is expected to grow at a CAGR of 9.2%, reaching $750 million by 2031.
This market includes four key product categories:
Market Insights & Data Coverage
Market Trends & Challenges
* The high cost of procedures remains a significant barrier for patients, even for those with private insurance.
* This cost is not expected to decline significantly over the forecast period, limiting unit sales.
* The FDA's approval of arthroscopic delivery methods for cartilage repair in 2024 enhances minimally invasive procedures and faster recovery times.
Market Share Insights
Top Competitors in the Global Orthopedic Cartilage Repair Market (2024):
1 Vericel - Market Leader
* Offers MACI(R), an autologous cartilage repair therapy for knee defects.
* The FDA-approved arthroscopic delivery method (August 2024) enables less invasive procedures.
2 Octane Medical Group - Second-Largest Competitor
* Expanded its portfolio by acquiring B. Braun's global orthobiologics business (TETEC AG, Aesculap Biologics).
* Offers NOVOCART(R) 3D (matrix-associated ACI system) and NOVOCART(R) Inject (injectable hydrogel-based cartilage repair).
3 Arthrex - Third-Largest Competitor
* Provides Allograft OATS(R), Autograft OATS(R), BioCartilage(R), and Cartiform(R) for osteochondral defect repair.
* The PowerPick system enables microdrilling for microfracture procedures.
Market Segmentation Summary
Global Research Scope
* North America (U.S., Canada)
* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
* Western Europe (Germany, France, U.K., Spain, Italy)
* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
* Middle East (Saudi Arabia, UAE, Israel)
* Asia Pacific (China, Japan, India, South Korea, Australia)
* Africa (South Africa, Egypt, Nigeria, Kenya)
Quantitative Coverage
Qualitative Coverage
Data Sources: